MSD Animal Health to Acquire Vilsan Pharmaceuticals Expands Product Portfolio in Turkey

ISTANBUL, TURKEY, November 14, 2017 – MSD Animal Health (known as Merck Animal Health in the United States and Canada) today announced it has signed an agreement to acquire Vilsan Pharmaceuticals, a division of Vimar Group, based in Turkey. Vilsan Pharmaceuticals is the largest privately-held producer of animal health products in Turkey, with an extensive portfolio of pharmaceutical products, notably for ruminants and a manufacturing facility.
"We are excited about the opportunity to expand and complement our MSD Animal Health portfolio with products from Vilsan Pharmaceuticals, which will bring value and new options to our customers in this growing region,” said Philippe Houffschmitt, General Manager, MSD Animal Health Turkey.

The agriculture industry is an important driver of the economy in Turkey, the second most populous country in Europe. Turkey is experiencing robust growth in the value of animal production, driven by the increased demand for protein.

"We are very pleased to join with MSD Animal Health to build upon our 30-year commitment to advance the health of animals,” said Burhan Haci, CEO of Vilsan Pharmaceuticals. "Their expertise, commercial reach and worldwide network, combined with our portfolio and production capacity, represents a tremendous opportunity to serve producers and veterinarians in this region.”  

The terms of the agreement were not disclosed. This agreement is subject to regulatory review and certain closing conditions, and is expected to close in the coming months.